Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 kidney transplant study group

Transplantation

Volumn 66, Issue 12, 1998, Pages 1736-1740

  Solez, Kim ^a   Vincenti, Flavio ^b   Filo, Ronald S ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; TACROLIMUS;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BIOPSY; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032573717     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812270-00029     Document Type: Article

References (17)

1. Pirsch JD, Miller J, Deierhoi MH, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977.
2. Ferguson R. Acute rejection episodes: best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant 1994; 8: 328.
3. Bassadona GP, Matas AJ, Gillingham KJ. Early vs late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
4. Mayer AD, Dmitrewski J, Squifflet J-P, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection. Transplantation 1997; 64: 436.
5. Solez K, Racusen LC. Banff classification analysis of renal morshy; phology in clinical trials of tacrolimus (FK506) vs. cyclosporine (CsA) in renal transplantation. Presented in abstract form at the 16th Annual Meeting of the American Society of Transplant Physicians, May 11-14, 1997, Chicago, IL.
6. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 45: 411.
7. COSTART. Coding symbols for thesaurus of adverse reaction terms, 3rd ed. Washington, DC: Department of Health and Human Services, Public Health Services, Food and Drug Administration, 1989.
8. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Transplantation 1995; 59: 511.
9. Seron D, Moreso F, Bover J, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997; 51: 310.
10. Cecka JM, Cho YW, Terasaki PI. Analysis of the UNOS scientific renal transplant registry at three years: early events affecting transplant success. Transplantation 1992; 53: 59.
11. Almond PS, Matas A, Gillingham KJ, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
12. Lindholm A, Ohlman S, Albrechtsen D, et al. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56: 307.
13. Martin M. Combination protocols for prevention of CMV disease in the high risk transplant patient. Transplant Proc 1996; 28 (suppl 2): 12.
14. Hayry P. Molecular pathology of acute and chronic rejection. Transplant Proc 1994; 26: 3280.
15. Loebe M, Schuler S, Zais O, et al. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 1990; 9: 707.
16. O'Grady JG, Alexander GJM, Sutherland S, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile duct syndrome after liver transplantation. Lancet 1988; 2: 302.
17. Pirsch J. CMV infections in renal transplant recipients: results of the U.S. multicenter FK506 kidney transplant study. International Congress on Immunosuppression, Dec. 11-13, 1997, Orlando, Fl, A40, 1997.